Advertisement

Topics

EU CHMP OKs New Treatments For MS, Esophagitis, CMV, Hemophilia – & First Biosimilar Avastin

07:11 EST 13 Nov 2017 | SCRIP

The EMA’s scientific committee, the CHMP, has given the green light to new treatments for multiple sclerosis, eosinophilic esophagitis, CMV...

      

Related Stories

 

Original Article: EU CHMP OKs New Treatments For MS, Esophagitis, CMV, Hemophilia – & First Biosimilar Avastin

NEXT ARTICLE

More From BioPortfolio on "EU CHMP OKs New Treatments For MS, Esophagitis, CMV, Hemophilia – & First Biosimilar Avastin"

Advertisement
Quick Search
Advertisement
Advertisement